The headlines are everywhere: Trump is set to reschedule marijuana from Schedule I to Schedule III. Cannabis stocks surged over 50% on the news. Industry leaders are calling it “the single most important drug policy move in decades.” I’ll admit, my first reaction was cautiously optimistic. Finally, some movement on an issue where federal policy […]

